Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P150004/S091

DRG Neurostimulation System

ABBOTT MEDICAL · Decision date Sep 25, 2025

FDA DECISIONP150004/S091

What did the FDA decide?

FDA records P150004/S091 as a supplement to PMA P150004, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Sep 25, 2025.

FDA approval order statement

the following changes for the shaft of the torque wrench accessory of the approved SCS, DBS, and DRG Neurostimulation systems: 1) Second-tier supplier manufacturing process relocation2) Validation of new, equivalent equipment at new site
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Neurology
Decision date
Sep 25, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P150004/S091
Regulatory pathway
PMA supplement
Product code
PMP
Decision code
OK30
Decision date
Sep 25, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Dorsal root ganglion stimulator for pain relief.

Product code
PMP
FDA device class
3

For the original device and its historical approval scope, see PMA P150004. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P150004 · Original PMA

    Axium Neurostimulator System

  2. P150004/S091 received

    Application receipt date recorded by FDA.

  3. P150004/S089 · Related supplement

    Proclaim Doral Root Ganglion (DRG) IPG

  4. P150004/S091 · FDA decision

    30-Day Notice

  5. P150004/S090 · Related supplement

    Dorsal Root Ganglion (DRG) Neurostimulation System

  6. P150004/S092 · Related supplement

    Proclaim Dorsal Root Ganglion (DRG) System

  7. P150004/S085 · Related supplement

    Proclaim Dorsal Root Ganglion (DRG) Neurostimulator System

  8. P150004/S093 · Related supplement

    Proclaim Doral Root Ganglion (DRG) IPG

  9. P150004/S094 · Related supplement

    Proclaim Dorsal Root Ganglion (DRG) IPG

  10. P150004/S095 · Related supplement

    Dorsal Root Ganglion (DRG) Implantable Pulse Generator (IPG)

  11. P150004/S099 · Related supplement

    Dorsal Root Ganglion (DRG) IPG

  12. P150004/S101 · Related supplement

    Dorsal Root Ganglion Stimulation (DRG) EPG

Timeline entries are records held by MedtechLedger for P150004. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P150004

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA approvalFeb 11, 2016FDA
Proclaim DRG IPGP150004/S087
ABBOTT MEDICALPMA supplementJul 23, 2025FDA
ABBOTT MEDICALPMA supplementAug 29, 2025FDA
ABBOTT MEDICALPMA supplementSep 26, 2025FDA
ABBOTT MEDICALPMA supplementNov 7, 2025FDA
ABBOTT MEDICALPMA supplementDec 23, 2025FDA
ABBOTT MEDICALPMA supplementJan 13, 2026FDA
ABBOTT MEDICALPMA supplementMar 13, 2026FDA
ABBOTT MEDICALPMA supplementApr 30, 2026FDA
ABBOTT MEDICALPMA supplementJun 30, 2026FDA
ABBOTT MEDICALPMA supplementJul 26, 2026FDA
Proclaim DRG IPGP150004/S100
ABBOTT MEDICALPMA supplementSep 23, 2026FDA
ABBOTT MEDICALPMA supplementOct 28, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
6901 Preston Rd., Plano, TX, 75024

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records